So far, no treatments are available to block or slow-down the HD pathologic process, albeit mutant huntingtin lowering strategies are currently tested in clinical trials as promising therapeutic (Hoffmann-La Roche, 2020; Wave Life Sciences Ltd, 2020). The gene discussed is HTT; the disease is Huntington disease.